This has been seen in individuals at risk of developing AD such as APOE4 carriers, those carrying autosomal dominant mutations linked with familial AD or patients with mild cognitive impairment.3 As hypometabolism is the earliest significant event linked with AD, it suggests that changes in energy metabolism precede neuronal loss and may actually contribute to the development and progression of the disease. Here, APOE is linked to Alzheimer disease.